4.3 Article

Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Obstetrics & Gynecology

Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study

Tasuku Harada et al.

Summary: This study evaluated the efficacy and safety of 40-mg relugolix compared with leuprorelin in treating endometriosis-associated pain. The results demonstrated that relugolix was noninferior to leuprorelin in relieving pelvic pain, and both medications had comparable safety profiles.

FERTILITY AND STERILITY (2022)

Article Medicine, General & Internal

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

Ayman Al-Hendy et al.

Summary: Once-daily relugolix combination therapy significantly reduces menstrual bleeding and preserves bone mineral density in women with uterine fibroids.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Environmental Sciences

Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists

Jacques Donnez et al.

Summary: Uterine adenomyosis is a common chronic disorder in reproductive-age women, causing heavy menstrual bleeding, intense pelvic pain, and infertility. Despite the unclear etiopathogenesis, high estrogen levels and progesterone resistance play key roles, leading to the use of antiestrogenic therapies for symptom management.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Obstetrics & Gynecology

Classification and Reporting Systems for Adenomyosis

Malcolm G. Munro

JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2020)

Article Obstetrics & Gynecology

Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea

Yutaka Osuga et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2020)

Article Obstetrics & Gynecology

Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis

Olivier Donnez et al.

FERTILITY AND STERILITY (2020)

Review Obstetrics & Gynecology

Endometriosis and nuclear receptors

Bahar D. Yilmaz et al.

HUMAN REPRODUCTION UPDATE (2019)

Review Obstetrics & Gynecology

Role of medical therapy in the management of uterine adenomyosis

Silvia Vannuccini et al.

FERTILITY AND STERILITY (2018)

Review Obstetrics & Gynecology

Pathogenesis of uterine adenomyosis: invagination or metaplasia?

Javier Garcia-Solares et al.

FERTILITY AND STERILITY (2018)

Article Medicine, General & Internal

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

H. S. Taylor et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Obstetrics & Gynecology

Pathogenesis of adenomyosis: an update on molecular mechanisms

Silvia Vannuccini et al.

REPRODUCTIVE BIOMEDICINE ONLINE (2017)

Article Obstetrics & Gynecology

Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial

Muhammad Fawzy et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)

Article Obstetrics & Gynecology

Is adenomyosis associated with menorrhagia?

J. Naftalin et al.

HUMAN REPRODUCTION (2014)

Review Medicine, General & Internal

Uterine Fibroids

Serdar E. Bulun

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Obstetrics & Gynecology

Understanding adenomyosis: a case control study

F. Andrei Taran et al.

FERTILITY AND STERILITY (2010)

Article Cell Biology

Progesterone resistance in endometriosis: Link to failure to metabolize estradiol

SE Bulun et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)